The Genetic and Scientific Basis, Molecular Biology, and Mechanistic Rationale for Lowering LDL Through PCSK9 Inhibition in the Diabetes Population: Translating Genetic and Epidemiologic Evidence to the Front Lines of Clinical research and Patient Care